You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

TRENTAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Trental patents expire, and when can generic versions of Trental launch?

Trental is a drug marketed by Validus Pharms and is included in one NDA.

The generic ingredient in TRENTAL is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trental

A generic version of TRENTAL was approved as pentoxifylline by RISING on July 8th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRENTAL?
  • What are the global sales for TRENTAL?
  • What is Average Wholesale Price for TRENTAL?
Summary for TRENTAL
Drug patent expirations by year for TRENTAL
Recent Clinical Trials for TRENTAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 4
Tanta UniversityEarly Phase 1
Misr University for Science and TechnologyPhase 2

See all TRENTAL clinical trials

US Patents and Regulatory Information for TRENTAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRENTAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 ⤷  Sign Up ⤷  Sign Up
Validus Pharms TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TRENTAL

See the table below for patents covering TRENTAL around the world.

Country Patent Number Title Estimated Expiration
Germany 1545687 ⤷  Sign Up
Germany 1233405 Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen ⤷  Sign Up
Germany 1250968 ⤷  Sign Up
Belgium 668977 ⤷  Sign Up
Netherlands 6511581 ⤷  Sign Up
Sweden 345459 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.